Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Cabaletta Bio (CABA)
NASDAQ:CABA
Cabaletta Bio (CABA) Stock Price & Analysis
225 Followers
CABA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.59 - $12.82
Previous Close$12.37
Volume376.74K
Average Volume (3M)877.32K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$85.89M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-7.0
Beta2.98
Next EarningsMar 15, 2023
EPS Estimate-$0.44
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$12.60
EPS (TTM)-1.78
Shares Outstanding29,140,810
R-Squared0.10
Standard Deviation0.46
10 Day Avg. Volume778,073
30 Day Avg. Volume877,317
Price to Book (P/B)4.14
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-9.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-0.16% Downside
Rating ConsensusStrong Buy
Alpha0.06
Number of Analyst Covering5
Cabaletta Bio News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CABA FAQ
What was Cabaletta Bio’s price range in the past 12 months?
Cabaletta Bio lowest stock price was $0.59 and its highest was $12.82 in the past 12 months.
What is Cabaletta Bio’s market cap?
Currently, no data Available
When is Cabaletta Bio’s upcoming earnings report date?
Cabaletta Bio’s upcoming earnings report date is Mar 15, 2023 which is in 35 days.
How were Cabaletta Bio’s earnings last quarter?
Cabaletta Bio released its earnings results on Nov 10, 2022. The company reported -$0.39 earnings per share for the quarter, beating the consensus estimate of -$0.45 by $0.06.
Is Cabaletta Bio overvalued?
According to Wall Street analysts Cabaletta Bio’s price is currently Overvalued.
Does Cabaletta Bio pay dividends?
Cabaletta Bio does not currently pay dividends.
What is Cabaletta Bio’s EPS estimate?
Cabaletta Bio’s EPS estimate is -$0.44.
How many shares outstanding does Cabaletta Bio have?
Cabaletta Bio has 29,140,810 shares outstanding.
What happened to Cabaletta Bio’s price movement after its last earnings report?
Cabaletta Bio reported an EPS of -$0.39 in its last earnings report, beating expectations of -$0.45. Following the earnings report the stock price went up 4.639%.
Which hedge fund is a major shareholder of Cabaletta Bio?
Among the largest hedge funds holding Cabaletta Bio’s share is Deerfield Management Company, LP. It holds Cabaletta Bio’s shares valued at 302K.
---
Cabaletta Bio Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.60
$12.60
Blogger Sentiment
Bullish
CABA Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.6%
Last 30 Days ▲ 11.6%
Last 30 Days ▲ 11.6%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
317.90%
12-Months-Change
Fundamentals
Return on Equity
-50.54%
Trailing 12-Months
Asset Growth
-25.25%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cabaletta Bio
Cabaletta Bio, Inc. operates as a clinical-stage biotechnology company, which engages in the discovery and development of engineered T cell therapies for B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor to selectively bind and eliminate B cells that produce disease-causing autoantibodies. The company was founded by Michael C. Milone, Steven Nichtberger, and Aimee Payne in 2017 and is headquartered in Philadelphia, PA.
---
---